A. T. Baykal, "Proteomic alterations in the cerebellum and hippocampus in an Alzheimer’s disease mouse model: Alleviating effect of palmatine," BIOMEDICINE AND PHARMACOTHERAPY , vol.158, no.158, pp.114111, 2023
Baykal, A. T. 2023. Proteomic alterations in the cerebellum and hippocampus in an Alzheimer’s disease mouse model: Alleviating effect of palmatine. BIOMEDICINE AND PHARMACOTHERAPY , vol.158, no.158 , 114111.
Baykal, A. T., (2023). Proteomic alterations in the cerebellum and hippocampus in an Alzheimer’s disease mouse model: Alleviating effect of palmatine. BIOMEDICINE AND PHARMACOTHERAPY , vol.158, no.158, 114111.
Baykal, AHMET. "Proteomic alterations in the cerebellum and hippocampus in an Alzheimer’s disease mouse model: Alleviating effect of palmatine," BIOMEDICINE AND PHARMACOTHERAPY , vol.158, no.158, 114111, 2023
Baykal, AHMET T. . "Proteomic alterations in the cerebellum and hippocampus in an Alzheimer’s disease mouse model: Alleviating effect of palmatine." BIOMEDICINE AND PHARMACOTHERAPY , vol.158, no.158, pp.114111, 2023
Baykal, A. T. (2023) . "Proteomic alterations in the cerebellum and hippocampus in an Alzheimer’s disease mouse model: Alleviating effect of palmatine." BIOMEDICINE AND PHARMACOTHERAPY , vol.158, no.158, p.114111.
@article{article, author={AHMET TARIK BAYKAL}, title={Proteomic alterations in the cerebellum and hippocampus in an Alzheimer’s disease mouse model: Alleviating effect of palmatine}, journal={BIOMEDICINE AND PHARMACOTHERAPY}, year=2023, pages={114111} }